UroAlert - GU Oncology Daily

July 13, 2026

Videos

Peer-to-Peer Clinical Conversations

The LuRa Study of Radium-223 After Prior Lutetium-177-PSMA-617 in mCRPC - Kambiz Rahbar

Kambiz Rahbar

Kambiz Rahbar presents the LuRa study, a retrospective four-center German analysis of 67 heavily pretreated mCRPC patients who received radium-223 after prior lutetium-177 PSMA therapy.

SunRISe-1 Cohort 4 Analysis: One-Year Disease-Free Survival in BCG-Unresponsive Papillary Bladder Cancer - Siamak Daneshmand

Siamak Daneshmand

Siamak Daneshmand presents SunRISe-1 Cohort 4 one-year results for gemcitabine intravesical system (Gem-iDRS), INLEXZO™ (gemcitabine intravesical system; formerly TAR-200) in BCG-unresponsive papillary NMIBC.

Beyond the Abstracts

Diagnosis, Evaluation, and Management of Patients with Non-Muscle Invasive Bladder Cancer - Beyond the Abstract

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium - Beyond the Abstract

Conference Coverage

ASCO 2026: Cabozantinib + Nivolumab versus Sunitinib in Patients with Advanced RCC and Bone Metastasis: Updated Subgroup Analysis of the Phase 3 CheckMate-9ER Trial

ASCO 2026: Phase II Study of Frontline Gemcitabine, 5-Flurouracil/leucovorin, and Cisplatin in Advanced Urachal and Non-Urachal Urinary Tract Adenocarcinoma

ASCO 2026: Association of GLP-1 Receptor Agonist Therapy with BCG Response in High-Risk NMIBC

AUA 2026: A Real World Evidence Study Assessing the Prevalence and Prognostic Value of FGFR Alterations in Patients with Intermediate Risk NMIBC

EAU 2026: Discussant: The EV-304 Paradigm Shift

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Comparative effectiveness of intravesical gemcitabine vs. sequential gemcitabine and docetaxel for high-risk nonmuscle-invasive bladder cancer.

Proteomic analysis of sphingolipid metabolic enzymes with risk of bladder cancer incidence and mortality in the Atherosclerosis Risk in Communities (ARIC) Study.

Penile & Urethral Cancers

Unmet needs in penile cancer: Review and perspectives from the Global Society of Rare Genitourinary Tumors.

Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Renal Cancer

Robotic partial nephrectomy is inching toward the gold standard for small renal masses-a narrative review.

De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When?

Prostate Cancer

The performance of prostate-specific antigen density in long-term prostate cancer-mortality risk prediction.

Impact of number of bone metastases on cancer control outcomes in mHSPC, independent of the axial-skeleton CHAARTED definition.

Dosimetric analysis of post-radiotherapy sexual dysfunction in patients receiving definitive stereotactic body radiotherapy (SBRT) for prostate cancer: a secondary analysis of MIRAGE.

68Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data.

Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617.

No racial disparities in prostate cancer-specific mortality after biochemical recurrence following radical prostatectomy or radiation therapy.

Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States.

Upper Tract Tumors

Longitudinal utDNA dynamics predict recurrence risk in upper tract urothelial carcinoma: A prospective cohort study.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC